RAPS Convergence Delivers on
What Global Regulatory Professionals Need

 
98% of RAPS Convergence 2020 virtual attendees indicated they would attend the virtual event in September 2021
96.4% Quality of speakers
92.4% Quality of content
90.4% Overall relevance of content to job responsibilities
88.4% Overall virtual conference experience
81.2% Ability to learn about innovations, products, and solutions
82.6% RAPS Convergence provides me with essential connections, information, education, and resources to do my job
80.4% RAPS Convergence is a good investment for my training dollars
70.0% RAPS Convergence 2020 live online met my professional development needs
77.4% RAPS Convergence is a “must attend” event

 

 

Region
USA 84.0%
Canada 4.2%
Asia 2.1%
Australia/Oceania 0.5%
Europe 8.0%
Africa 0.2%
LATAM 1.1%
Organization Type
Laboratory 1.3%
Law Firm 0.4%
Media 0.2%
Notified Body 2.1%
Prefer not to answer 2.7%
Not-for-profit/Association 14.0%
Other 9.5%
Self-Employed 2.2%
Software 4.0%
Talent Acquisition 0.1%
Academic Institution 1.9%
Translations 0.3%
Consulting Firm 11.2%
Clinical Research Organization (CRO) 2.1%
Training/Education 0.4%
Hospital/Medical Practice 0.9%
Industry Organization 46.8%
Professional Interests
Medical Devices 19.4%
Prefer not to answer 1.9%
Nutritional/Natural Health 1.8%
Orphan Products 5.8%
OTC Drugs 2.7%
Other 0.5%
Biotechnology 9.2%
Veterinary Medicines 1.2%
APIs 3.3%
Biologics 10.9%
Cosmetics 1.6%
Combination Products 11.7%
Foods 1.2%
Generic Drugs 2.9%
Biosimilars/Generic 4.0%
Innovative Pharmaceuticals 8.7%
IVDs 9.4%
Biomaterials 3.7%

 

 

Purchasing Authority
Influence purchase decisions 84.0%
Research new technology,
products and/or services		 4.2%
No role 2.1%
Recommend technology,
products and/or services
and/or specify vendors		 0.5%
Final decision maker 8.0%
71% Involved in the purchase process
Annual Purchasing Power
Unsure/not applicable 56%
Less than $100,000 28%
$100,000 - $500,000 8%
$500,001 - $1,000,000 6%
$1,000,001 - $5,000,000 3%
More than $5,000,000 3%
Product Purchasing Intentions
(next 12 months)
Biotechnology 14%
Communications 6%
Conformity assessments 13%
Consulting 32%
Clinical research organization (CRO) 15%
Education and training 38%
Legal 9%
Marketing 4%
Medical devices 30%
Notified Body 21%
Pharmaceutical 19%
Recruitment and staffing 14%
Regulatory information management 30%
Regulatory intelligence 34%
Software 20%
Translation 13%
Other 10%